Clinical trials
Cicatrix, Hypertrophic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
127 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 6 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 9 |
| 2018 | 8 |
| 2019 | 10 |
| 2020 | 10 |
| 2021 | 8 |
| 2022 | 11 |
| 2023 | 8 |
| 2024 | 6 |
| 2025 | 11 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 52 |
| Unknown status | 34 |
| Recruiting | 14 |
| Withdrawn | 10 |
| Not yet recruiting | 10 |
| Terminated | 5 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cairo University | 10 |
| Hangang Sacred Heart Hospital | 3 |
| Mahidol University | 3 |
| Massachusetts General Hospital | 3 |
| The Hong Kong Polytechnic University | 3 |
| Alexandria University | 2 |
| Amsterdam UMC, location VUmc | 2 |
| Assiut University | 2 |
| Henry Ford Health System | 2 |
| Hugel | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cicatrix, Hypertrophic | 127 |
| Keloid | 40 |
| Cicatrix | 37 |
| Burns | 17 |
| Hypertrophy | 3 |
| Surgical Wound | 3 |
| Fibrosis | 2 |
| Hyperpigmentation | 2 |
| Postoperative Pain | 2 |
| Pruritus | 2 |
Trials
Showing 51 to 75 of 127. Each trial links to its page on Pharma Observatory.
27 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.